Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up

Using PET imaging to define esophageal cancer boundaries

Official title: Predicting Esophageal Cancer Borders Using PET-Imaging PEGASUS

Run by University Hospital Heidelberg · NCT06408116 · Data updated 2026-11-12

This study is testing if using advanced imaging techniques can help doctors better see the edges of esophageal tumors in patients before and after treatment to improve surgery and reduce the chance of cancer coming back.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorUniversity Hospital Heidelberg
Academic / other
Drugs / interventionsradiation, chemotherapy
Locations1 site (Heidelberg)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedJanuary 2028
Study endsApril 2028
Registry record updatedMarch 10, 2026
Trial IDNCT06408116 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with histologically confirmed adenocarcinoma or squamous cell carcinoma of the esophagus who are planned for surgical treatment.

Probably not a fit

Patients with distant metastasis, previous radiation therapy in the tumor region, or those unable to provide consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of endosonography, mpMRI, and PET/CT imaging in accurately determining the boundaries of esophageal tumors before and after neoadjuvant therapy and surgery. It aims to improve the precision of tumor delineation, which is crucial for effective treatment planning in patients with esophageal cancer. By enhancing the accuracy of tumor boundary identification, the study seeks to minimize the risk of cancer recurrence and improve surgical outcomes. The trial is conducted at the University Hospital Heidelberg in Germany, focusing on patients with specific types of esophageal cancer.

Why it matters

Potential benefit: If successful, this approach could lead to more precise treatment planning and improved outcomes for patients with esophageal cancer.

How similar studies have gone: While similar imaging techniques have been explored in other studies, this specific approach using PET imaging for esophageal cancer boundaries is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Histologically confirmed adenocarcinoma or squamous cell carcinoma of the esophagus, including AEG I and AEG II tumors in the primary situation
* Planned surgical treatment of esophageal carcinoma
* Possible staging advantage through FAPI PET/CT diagnostics
* Patient information and written consent

  -\> KI 60% or ECOG 0/1 (at least: self-sufficiency)
* Age ≥ 18 years

Exclusion Criteria:

* Previous radiation therapy in the tumor region
* Previous tumor disease with \< 5 years of remission
* Surgical therapy is not functionally or technically possible
* Distant metastasis
* Patient is not capable of giving consent
* Concurrent participation in another clinical trial that could affect the results of this trial or the other trial
* Illnesses that do not allow the person concerned to assess the nature and scope as well as possible consequences of the clinical study
* pregnant or breastfeeding women
* Signs that the person taking part is unlikely to comply with the therapy (e.g. unwillingness to cooperate)

Where it's running

  • Department of Radiotherapy, University of Heidelberg
    Heidelberg, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.